Status:

UNKNOWN

Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis

Lead Sponsor:

Shanghai University of Traditional Chinese Medicine

Conditions:

Ankylosing Spondylitis

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to determine whether Bawei Shenqi Pill is effective in the treatment of active ankylosing spondylitis (AS).

Detailed Description

Ankylosing spondylitis is a chronic inflammatory disease, which mainly invades sacroiliac joint, spinal osteoid process, paraspinal soft tissue and peripheral joints, and can be accompanied by extraar...

Eligibility Criteria

Inclusion

  • Compliance with New York standards revised in 1984
  • Syndrome differentiation of traditional Chinese medicine for deficiency of kidney-yang
  • 18 to 70 years of age, male and female
  • Being able to understand or sign an informed consent form

Exclusion

  • Other spondyloarthropathy that does not meet the diagnostic criteria of ankylosing spondylitis, and TCM syndrome differentiation does not belong to kidney-yang deficiency type.
  • Age is out of range
  • Do not agree to participate in this topic or can not participate in the whole process
  • Complicated with other rheumatic diseases or other seronegative spondyloarthropathy.
  • Pregnant, lactating women and patients with serious visceral diseases, mental disorders and severe extraarticular manifestations, such as heart, lung, liver, kidney or hematopoietic system.
  • Have had myocardial infarction or stroke, congestive heart failure and active digestive tract ulcer patients.
  • Those who had received other research drugs three months before screening.
  • Inability or unwillingness to provide informed consent or failure to comply with test requirements.
  • The researchers believe that it is not suitable for the owners of the study.

Key Trial Info

Start Date :

October 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2020

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04480359

Start Date

October 1 2017

End Date

September 30 2020

Last Update

August 14 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai, Shanghai Municipality, China, 200030